Long-Term Remissions with MRD-Guided Acalabrutinib, Venetoclax and Obinutuzumab in Relapsed/Refractory CLL: Follow-up Efficacy and Circulating Tumor DNA Analysis of the CLL2-Baag TrialMoritz Furstenau,Adam Giza,Anna-Maria Fink,Sandra Robrecht,Jonathan Weiss, Fanni Kleinert,Christof Schneider,Eugen Tausch,Kirsten Fischer,Petra Langerbeins,Othman Al-Sawaf,Johannes Schetelig,Peter Dreger,Sebastian Böttcher,Karl-Anton Kreuzer,Matthias Ritgen,Anke Schilhabel,Monika Brüggemann,Stephan Stilgenbauer,Barbara F. EichhorstBlood(2023)引用 0|浏览13暂无评分摘要Background更多查看译文AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要